Advanced search
Publication Cover
Upsala Journal of Medical Sciences Volume 117, 2012 - Issue 1
Journal homepage
697
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Common variable immunodeficiency complicated with hemolytic uremic syndrome

Biljana MiloševićDepartment of Nephrology, Institute for Child and Youth Health Care of Vojvodina, Novi Sad, Serbia
,
Vesna StojanovićIntensive Care Unit, Institute for Child and Youth Health Care of Vojvodina, Novi Sad, SerbiaCorrespondence[email protected]
,
Marko NikolićIntensive Care Unit, Institute for Child and Youth Health Care of Vojvodina, Novi Sad, Serbia
,
Georgios KonstantinidisIntensive Care Unit, Institute for Child and Youth Health Care of Vojvodina, Novi Sad, Serbia
&
Andrija RudićDepartment of Immunology and Allergology, Institute for Child and Youth Health Care of Vojvodina, Novi Sad, Serbia
Pages 67-71 | Received 13 Apr 2011, Accepted 20 Oct 2011, Published online: 07 Nov 2011

References

  • Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet. 2008;372:489–502.
  • Schroeder HW Jr, Schroeder HW 3rd, Sheikh SM. The complex genetics of common variable immunodeficiency. J Investig Med. 2004;52:90–103.
  • Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94(5 Suppl 1):S1–63.
  • Fasth A. Primary immunodeficiency disorders in Sweden: cases among children, 1974–1979. J Clin Immunol. 1982;2:86–92.
  • Cunningham-Rundles C. Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol. 2008;28(Suppl 1):S42–5.
  • Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48.
  • Cunningham-Rundles C. Immune deficiency: office evaluation and treatment. Allergy Asthma Proc. 2003;24:409–15.
  • Cunningham-Rundles C, Siegal FP, Smithwick EM, Lion-Boule A, Cunningham-Rundles S, O’Malley J, Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann Intern Med. 1984;101:435–9.
  • Nolte MT, Pirofsky B, Gerritz GA, Golding B. Intravenous immunoglobulin therapy for antibody deficiency. Clin Exp Immunol. 1979;362:237–43.
  • Quartier P, Debre M, De Blic J, de Sauverzac R, Sayegh N, Jabado N, Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinaemia: a retrospective survey of 31 patients. J Pediatr. 1999;134:589–96.
  • Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol. 2009;145:709–27.
  • Liobet MP, Soler-palacin P, Detkova D, Hernandez M, Caragol I, Espanol T. Common variable immunodeficiency: 20-yr experience at a single centre. Pediatr Allergy Immunol. 2009;20:113–8.
  • Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16:1035–50.
  • Corrigan JJ Jr, Boineau FG. Hemolytic-uremic syndrome. Pediatr Rev. 2001;22:365–9.
  • Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol. 2008;3:249–77.
  • Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol. 2009;24:687–96.
  • Siegler R, Oakes R. Hemolytic uremic syndrome; pathogenesis, treatment, and outcome. Curr Opin Pediatr. 2005;17:200–4.
  • Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112:277–86.
  • Morimoto Y, Routes JM. Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep. 2005;5:370–5.
  • Thicket KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE. Common variable immune deficiency: respiratory manifestation, pulmonary function and high-resolution CT scan findings. QJM. 2002;95:655–62.
  • Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol. 2002;14:548–52.
  • Grom AA, Passo M. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediatr. 1996;129:630–2.
  • Arico J, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia. 1996;10:197–203.
  • Stabile A, Bertoni B, Ansuini V, La Torraca I, Salli A, Rigante D. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. Eur Rev Med Pharmacol Sci. 2006;10:53–9.
  • Tang Y, Xu X. Advances in hemophagocytic lymphohistiocytosis: pathogenesis, early diagnosis/differential diagnosis, and treatment. Sci World J. 2011;11:697–708.
  • Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, Long-term follow up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27:308–16.
  • Garimella-Krovi S, Panner JB, Springate EJ. Renal disease in common variable immunodeficiency-case report and literature review. Pediatr Asthma Allergy Immunol. 2008;21:35–9.
  • Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: clinical experience in 108 patients. N Engl J Med. 1991;325:398–403.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.